Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that ...

An estimated 828 million adults (420 women, 408 men) had diabetes in 2022, an increase of 630 million since 1990. India (212 ...

Transpire Bio expands headquarters in Weston, adding 6,600 square feet. New executives join, including Stuart Loesch and Todd ...

Healthcare stocks were falling Friday morning after noted anti-vaccine crusader Robert F. Kennedy Jr. was announced as ...

TORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased to announce the appointment of Faisal Mehmud, MD as Chief Medical ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

The global dietary supplement market revenue is poised for significant growth, with projections indicating it will attain a valuation of approximately USD 170.1 billion by 2034. T ...

President-elect Trump’s decision to nominate Robert F. Kennedy Jr. for Health and Human Services (HHS) secretary will put ...

Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved ...

GlaxoSmithKline Pharmaceuticals on Tuesday reported a 16 per cent year-on-year increase in its consolidated net profit to Rs 252 crore in the September quarter, aided by robust sales across segments.

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...